nodes	percent_of_prediction	percent_of_DWPC	metapath
Zolpidem—CYP2D6—Fingolimod—multiple sclerosis	0.0843	0.157	CbGbCtD
Zolpidem—CYP3A4—Fingolimod—multiple sclerosis	0.0536	0.0995	CbGbCtD
Zolpidem—CYP3A7-CYP3A51P—Dexamethasone—multiple sclerosis	0.0447	0.0829	CbGbCtD
Zolpidem—CYP3A7—Dexamethasone—multiple sclerosis	0.0447	0.0829	CbGbCtD
Zolpidem—CYP2C19—Prednisone—multiple sclerosis	0.0433	0.0804	CbGbCtD
Zolpidem—CYP3A4—Methylprednisolone—multiple sclerosis	0.0346	0.0641	CbGbCtD
Zolpidem—CYP3A5—Dexamethasone—multiple sclerosis	0.0335	0.0622	CbGbCtD
Zolpidem—CYP2C19—Dexamethasone—multiple sclerosis	0.027	0.0502	CbGbCtD
Zolpidem—CYP3A4—Triamcinolone—multiple sclerosis	0.0262	0.0486	CbGbCtD
Zolpidem—CYP3A4—Mitoxantrone—multiple sclerosis	0.0252	0.0468	CbGbCtD
Zolpidem—CYP2C9—Dexamethasone—multiple sclerosis	0.0225	0.0417	CbGbCtD
Zolpidem—CYP3A4—Betamethasone—multiple sclerosis	0.0225	0.0417	CbGbCtD
Zolpidem—CYP3A4—Prednisolone—multiple sclerosis	0.0222	0.0411	CbGbCtD
Zolpidem—CYP3A4—Prednisone—multiple sclerosis	0.0209	0.0389	CbGbCtD
Zolpidem—CYP2D6—Dexamethasone—multiple sclerosis	0.0206	0.0381	CbGbCtD
Zolpidem—CYP3A4—Dexamethasone—multiple sclerosis	0.0131	0.0243	CbGbCtD
Zolpidem—GABRB2—brainstem—multiple sclerosis	0.00122	0.0435	CbGeAlD
Zolpidem—GABRA2—brainstem—multiple sclerosis	0.00112	0.0398	CbGeAlD
Zolpidem—GABRA1—brainstem—multiple sclerosis	0.00108	0.0385	CbGeAlD
Zolpidem—GABRB2—medulla oblongata—multiple sclerosis	0.000852	0.0304	CbGeAlD
Zolpidem—GABRG2—medulla oblongata—multiple sclerosis	0.000852	0.0304	CbGeAlD
Zolpidem—GABRA3—nervous system—multiple sclerosis	0.000785	0.028	CbGeAlD
Zolpidem—GABRG2—midbrain—multiple sclerosis	0.000778	0.0278	CbGeAlD
Zolpidem—GABRB2—midbrain—multiple sclerosis	0.000778	0.0278	CbGeAlD
Zolpidem—GABRB2—spinal cord—multiple sclerosis	0.000759	0.0271	CbGeAlD
Zolpidem—GABRG2—spinal cord—multiple sclerosis	0.000759	0.0271	CbGeAlD
Zolpidem—GABRA3—central nervous system—multiple sclerosis	0.000756	0.0269	CbGeAlD
Zolpidem—GABRA1—medulla oblongata—multiple sclerosis	0.000752	0.0268	CbGeAlD
Zolpidem—GABRA1—midbrain—multiple sclerosis	0.000687	0.0245	CbGeAlD
Zolpidem—GABRA1—spinal cord—multiple sclerosis	0.000671	0.0239	CbGeAlD
Zolpidem—GABRB3—medulla oblongata—multiple sclerosis	0.000654	0.0233	CbGeAlD
Zolpidem—GABRG2—nervous system—multiple sclerosis	0.00064	0.0228	CbGeAlD
Zolpidem—GABRB2—nervous system—multiple sclerosis	0.00064	0.0228	CbGeAlD
Zolpidem—GABRB2—central nervous system—multiple sclerosis	0.000616	0.022	CbGeAlD
Zolpidem—GABRG2—central nervous system—multiple sclerosis	0.000616	0.022	CbGeAlD
Zolpidem—GABRG2—cerebellum—multiple sclerosis	0.000602	0.0215	CbGeAlD
Zolpidem—GABRB2—cerebellum—multiple sclerosis	0.000602	0.0215	CbGeAlD
Zolpidem—GABRA3—brain—multiple sclerosis	0.0006	0.0214	CbGeAlD
Zolpidem—GABRB3—midbrain—multiple sclerosis	0.000598	0.0213	CbGeAlD
Zolpidem—GABRA2—nervous system—multiple sclerosis	0.000585	0.0208	CbGeAlD
Zolpidem—GABRB3—spinal cord—multiple sclerosis	0.000583	0.0208	CbGeAlD
Zolpidem—GABRA1—nervous system—multiple sclerosis	0.000565	0.0201	CbGeAlD
Zolpidem—GABRA2—central nervous system—multiple sclerosis	0.000563	0.0201	CbGeAlD
Zolpidem—GABRA2—cerebellum—multiple sclerosis	0.00055	0.0196	CbGeAlD
Zolpidem—GABRA1—central nervous system—multiple sclerosis	0.000544	0.0194	CbGeAlD
Zolpidem—GABRA1—cerebellum—multiple sclerosis	0.000532	0.019	CbGeAlD
Zolpidem—GABRB3—nervous system—multiple sclerosis	0.000491	0.0175	CbGeAlD
Zolpidem—GABRG2—brain—multiple sclerosis	0.000489	0.0174	CbGeAlD
Zolpidem—GABRB2—brain—multiple sclerosis	0.000489	0.0174	CbGeAlD
Zolpidem—GABRB3—central nervous system—multiple sclerosis	0.000473	0.0169	CbGeAlD
Zolpidem—CYP2D6—brainstem—multiple sclerosis	0.000472	0.0168	CbGeAlD
Zolpidem—GABRB3—cerebellum—multiple sclerosis	0.000462	0.0165	CbGeAlD
Zolpidem—GABRA2—brain—multiple sclerosis	0.000447	0.0159	CbGeAlD
Zolpidem—GABRA1—brain—multiple sclerosis	0.000432	0.0154	CbGeAlD
Zolpidem—GABRB3—brain—multiple sclerosis	0.000376	0.0134	CbGeAlD
Zolpidem—PTGS1—spinal cord—multiple sclerosis	0.000357	0.0127	CbGeAlD
Zolpidem—PTGS1—nervous system—multiple sclerosis	0.000301	0.0107	CbGeAlD
Zolpidem—PTGS1—central nervous system—multiple sclerosis	0.00029	0.0103	CbGeAlD
Zolpidem—CYP3A4—nervous system—multiple sclerosis	0.000252	0.00897	CbGeAlD
Zolpidem—CYP2D6—nervous system—multiple sclerosis	0.000248	0.00883	CbGeAlD
Zolpidem—CYP3A4—central nervous system—multiple sclerosis	0.000242	0.00864	CbGeAlD
Zolpidem—Infection—Triamcinolone—multiple sclerosis	0.000242	0.000599	CcSEcCtD
Zolpidem—Infection—Methylprednisolone—multiple sclerosis	0.000241	0.000598	CcSEcCtD
Zolpidem—Shock—Triamcinolone—multiple sclerosis	0.000239	0.000593	CcSEcCtD
Zolpidem—Insomnia—Prednisolone—multiple sclerosis	0.000239	0.000593	CcSEcCtD
Zolpidem—Shock—Methylprednisolone—multiple sclerosis	0.000239	0.000592	CcSEcCtD
Zolpidem—CYP2D6—central nervous system—multiple sclerosis	0.000238	0.0085	CbGeAlD
Zolpidem—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.000238	0.00059	CcSEcCtD
Zolpidem—Loss of consciousness—Dexamethasone—multiple sclerosis	0.000238	0.000589	CcSEcCtD
Zolpidem—Loss of consciousness—Betamethasone—multiple sclerosis	0.000238	0.000589	CcSEcCtD
Zolpidem—Epistaxis—Methotrexate—multiple sclerosis	0.000238	0.000589	CcSEcCtD
Zolpidem—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000238	0.000589	CcSEcCtD
Zolpidem—Paraesthesia—Prednisolone—multiple sclerosis	0.000238	0.000589	CcSEcCtD
Zolpidem—Tachycardia—Triamcinolone—multiple sclerosis	0.000237	0.000588	CcSEcCtD
Zolpidem—Mental disorder—Prednisone—multiple sclerosis	0.000237	0.000588	CcSEcCtD
Zolpidem—Nausea—Azathioprine—multiple sclerosis	0.000237	0.000587	CcSEcCtD
Zolpidem—Tachycardia—Methylprednisolone—multiple sclerosis	0.000237	0.000587	CcSEcCtD
Zolpidem—Skin disorder—Methylprednisolone—multiple sclerosis	0.000236	0.000584	CcSEcCtD
Zolpidem—Erythema—Prednisone—multiple sclerosis	0.000236	0.000584	CcSEcCtD
Zolpidem—Malnutrition—Prednisone—multiple sclerosis	0.000236	0.000584	CcSEcCtD
Zolpidem—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.000235	0.000583	CcSEcCtD
Zolpidem—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.000235	0.000582	CcSEcCtD
Zolpidem—Hypertension—Dexamethasone—multiple sclerosis	0.000234	0.000579	CcSEcCtD
Zolpidem—Hypertension—Betamethasone—multiple sclerosis	0.000234	0.000579	CcSEcCtD
Zolpidem—CYP2D6—cerebellum—multiple sclerosis	0.000233	0.00831	CbGeAlD
Zolpidem—Asthenia—Mitoxantrone—multiple sclerosis	0.000231	0.000573	CcSEcCtD
Zolpidem—Myalgia—Dexamethasone—multiple sclerosis	0.00023	0.000571	CcSEcCtD
Zolpidem—Myalgia—Betamethasone—multiple sclerosis	0.00023	0.000571	CcSEcCtD
Zolpidem—PTGS1—brain—multiple sclerosis	0.00023	0.00821	CbGeAlD
Zolpidem—Anxiety—Dexamethasone—multiple sclerosis	0.00023	0.000569	CcSEcCtD
Zolpidem—Anxiety—Betamethasone—multiple sclerosis	0.00023	0.000569	CcSEcCtD
Zolpidem—Discomfort—Dexamethasone—multiple sclerosis	0.000228	0.000564	CcSEcCtD
Zolpidem—Discomfort—Betamethasone—multiple sclerosis	0.000228	0.000564	CcSEcCtD
Zolpidem—Hypotension—Methylprednisolone—multiple sclerosis	0.000227	0.000562	CcSEcCtD
Zolpidem—Pain—Prednisolone—multiple sclerosis	0.000226	0.000561	CcSEcCtD
Zolpidem—Pharyngitis—Methotrexate—multiple sclerosis	0.000224	0.000556	CcSEcCtD
Zolpidem—Urinary tract disorder—Methotrexate—multiple sclerosis	0.000223	0.000553	CcSEcCtD
Zolpidem—Vision blurred—Prednisone—multiple sclerosis	0.000222	0.00055	CcSEcCtD
Zolpidem—Urethral disorder—Methotrexate—multiple sclerosis	0.000222	0.000549	CcSEcCtD
Zolpidem—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000222	0.000549	CcSEcCtD
Zolpidem—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000221	0.000548	CcSEcCtD
Zolpidem—Oedema—Dexamethasone—multiple sclerosis	0.000221	0.000547	CcSEcCtD
Zolpidem—Oedema—Betamethasone—multiple sclerosis	0.000221	0.000547	CcSEcCtD
Zolpidem—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.000221	0.000547	CcSEcCtD
Zolpidem—Anaphylactic shock—Betamethasone—multiple sclerosis	0.000221	0.000547	CcSEcCtD
Zolpidem—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000221	0.000547	CcSEcCtD
Zolpidem—Insomnia—Triamcinolone—multiple sclerosis	0.00022	0.000545	CcSEcCtD
Zolpidem—Insomnia—Methylprednisolone—multiple sclerosis	0.00022	0.000544	CcSEcCtD
Zolpidem—Infection—Betamethasone—multiple sclerosis	0.000219	0.000544	CcSEcCtD
Zolpidem—Infection—Dexamethasone—multiple sclerosis	0.000219	0.000544	CcSEcCtD
Zolpidem—Ill-defined disorder—Prednisone—multiple sclerosis	0.000219	0.000542	CcSEcCtD
Zolpidem—Paraesthesia—Triamcinolone—multiple sclerosis	0.000218	0.000541	CcSEcCtD
Zolpidem—Feeling abnormal—Prednisolone—multiple sclerosis	0.000218	0.00054	CcSEcCtD
Zolpidem—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000218	0.00054	CcSEcCtD
Zolpidem—Visual impairment—Methotrexate—multiple sclerosis	0.000218	0.00054	CcSEcCtD
Zolpidem—Anaemia—Prednisone—multiple sclerosis	0.000218	0.00054	CcSEcCtD
Zolpidem—Shock—Betamethasone—multiple sclerosis	0.000217	0.000538	CcSEcCtD
Zolpidem—Shock—Dexamethasone—multiple sclerosis	0.000217	0.000538	CcSEcCtD
Zolpidem—Dyspnoea—Triamcinolone—multiple sclerosis	0.000217	0.000538	CcSEcCtD
Zolpidem—Nervous system disorder—Dexamethasone—multiple sclerosis	0.000217	0.000537	CcSEcCtD
Zolpidem—Nervous system disorder—Betamethasone—multiple sclerosis	0.000217	0.000537	CcSEcCtD
Zolpidem—Agitation—Prednisone—multiple sclerosis	0.000216	0.000536	CcSEcCtD
Zolpidem—Tachycardia—Dexamethasone—multiple sclerosis	0.000215	0.000534	CcSEcCtD
Zolpidem—Tachycardia—Betamethasone—multiple sclerosis	0.000215	0.000534	CcSEcCtD
Zolpidem—Angioedema—Prednisone—multiple sclerosis	0.000215	0.000533	CcSEcCtD
Zolpidem—Dyspepsia—Triamcinolone—multiple sclerosis	0.000214	0.000531	CcSEcCtD
Zolpidem—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000214	0.00053	CcSEcCtD
Zolpidem—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.000213	0.000529	CcSEcCtD
Zolpidem—Hyperhidrosis—Betamethasone—multiple sclerosis	0.000213	0.000529	CcSEcCtD
Zolpidem—Malaise—Prednisone—multiple sclerosis	0.000212	0.000526	CcSEcCtD
Zolpidem—Vertigo—Prednisone—multiple sclerosis	0.000212	0.000524	CcSEcCtD
Zolpidem—Eye disorder—Methotrexate—multiple sclerosis	0.000211	0.000524	CcSEcCtD
Zolpidem—Syncope—Prednisone—multiple sclerosis	0.000211	0.000524	CcSEcCtD
Zolpidem—Tinnitus—Methotrexate—multiple sclerosis	0.000211	0.000523	CcSEcCtD
Zolpidem—Anorexia—Dexamethasone—multiple sclerosis	0.00021	0.000521	CcSEcCtD
Zolpidem—Anorexia—Betamethasone—multiple sclerosis	0.00021	0.000521	CcSEcCtD
Zolpidem—Urticaria—Prednisolone—multiple sclerosis	0.00021	0.000521	CcSEcCtD
Zolpidem—Cardiac disorder—Methotrexate—multiple sclerosis	0.00021	0.00052	CcSEcCtD
Zolpidem—Fatigue—Triamcinolone—multiple sclerosis	0.00021	0.00052	CcSEcCtD
Zolpidem—Fatigue—Methylprednisolone—multiple sclerosis	0.000209	0.000519	CcSEcCtD
Zolpidem—Pain—Triamcinolone—multiple sclerosis	0.000208	0.000516	CcSEcCtD
Zolpidem—Loss of consciousness—Prednisone—multiple sclerosis	0.000207	0.000513	CcSEcCtD
Zolpidem—Hypotension—Betamethasone—multiple sclerosis	0.000206	0.000511	CcSEcCtD
Zolpidem—Hypotension—Dexamethasone—multiple sclerosis	0.000206	0.000511	CcSEcCtD
Zolpidem—Vomiting—Mitoxantrone—multiple sclerosis	0.000205	0.000508	CcSEcCtD
Zolpidem—Mediastinal disorder—Methotrexate—multiple sclerosis	0.000204	0.000505	CcSEcCtD
Zolpidem—Hypertension—Prednisone—multiple sclerosis	0.000203	0.000504	CcSEcCtD
Zolpidem—Rash—Mitoxantrone—multiple sclerosis	0.000203	0.000504	CcSEcCtD
Zolpidem—Dermatitis—Mitoxantrone—multiple sclerosis	0.000203	0.000503	CcSEcCtD
Zolpidem—Chills—Methotrexate—multiple sclerosis	0.000203	0.000503	CcSEcCtD
Zolpidem—Headache—Mitoxantrone—multiple sclerosis	0.000202	0.000501	CcSEcCtD
Zolpidem—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000201	0.000498	CcSEcCtD
Zolpidem—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000201	0.000498	CcSEcCtD
Zolpidem—Myalgia—Prednisone—multiple sclerosis	0.000201	0.000497	CcSEcCtD
Zolpidem—Arthralgia—Prednisone—multiple sclerosis	0.000201	0.000497	CcSEcCtD
Zolpidem—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000201	0.000497	CcSEcCtD
Zolpidem—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.0002	0.000496	CcSEcCtD
Zolpidem—Anxiety—Prednisone—multiple sclerosis	0.0002	0.000495	CcSEcCtD
Zolpidem—Insomnia—Betamethasone—multiple sclerosis	0.0002	0.000495	CcSEcCtD
Zolpidem—Insomnia—Dexamethasone—multiple sclerosis	0.0002	0.000495	CcSEcCtD
Zolpidem—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.000199	0.000494	CcSEcCtD
Zolpidem—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000199	0.000492	CcSEcCtD
Zolpidem—Paraesthesia—Dexamethasone—multiple sclerosis	0.000198	0.000491	CcSEcCtD
Zolpidem—Paraesthesia—Betamethasone—multiple sclerosis	0.000198	0.000491	CcSEcCtD
Zolpidem—Discomfort—Prednisone—multiple sclerosis	0.000198	0.000491	CcSEcCtD
Zolpidem—Mental disorder—Methotrexate—multiple sclerosis	0.000198	0.000491	CcSEcCtD
Zolpidem—Erythema—Methotrexate—multiple sclerosis	0.000197	0.000488	CcSEcCtD
Zolpidem—Malnutrition—Methotrexate—multiple sclerosis	0.000197	0.000488	CcSEcCtD
Zolpidem—Hypersensitivity—Prednisolone—multiple sclerosis	0.000195	0.000483	CcSEcCtD
Zolpidem—Dyspepsia—Dexamethasone—multiple sclerosis	0.000194	0.000482	CcSEcCtD
Zolpidem—Dyspepsia—Betamethasone—multiple sclerosis	0.000194	0.000482	CcSEcCtD
Zolpidem—Urticaria—Triamcinolone—multiple sclerosis	0.000193	0.000479	CcSEcCtD
Zolpidem—Urticaria—Methylprednisolone—multiple sclerosis	0.000193	0.000478	CcSEcCtD
Zolpidem—Dysgeusia—Methotrexate—multiple sclerosis	0.000193	0.000478	CcSEcCtD
Zolpidem—Body temperature increased—Triamcinolone—multiple sclerosis	0.000192	0.000477	CcSEcCtD
Zolpidem—Anaphylactic shock—Prednisone—multiple sclerosis	0.000192	0.000476	CcSEcCtD
Zolpidem—Oedema—Prednisone—multiple sclerosis	0.000192	0.000476	CcSEcCtD
Zolpidem—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000192	0.000476	CcSEcCtD
Zolpidem—Decreased appetite—Dexamethasone—multiple sclerosis	0.000192	0.000476	CcSEcCtD
Zolpidem—Decreased appetite—Betamethasone—multiple sclerosis	0.000192	0.000476	CcSEcCtD
Zolpidem—Nausea—Mitoxantrone—multiple sclerosis	0.000192	0.000475	CcSEcCtD
Zolpidem—Infection—Prednisone—multiple sclerosis	0.000191	0.000473	CcSEcCtD
Zolpidem—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000191	0.000472	CcSEcCtD
Zolpidem—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000191	0.000472	CcSEcCtD
Zolpidem—Back pain—Methotrexate—multiple sclerosis	0.00019	0.000472	CcSEcCtD
Zolpidem—Fatigue—Betamethasone—multiple sclerosis	0.00019	0.000472	CcSEcCtD
Zolpidem—Fatigue—Dexamethasone—multiple sclerosis	0.00019	0.000472	CcSEcCtD
Zolpidem—CYP2C9—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.00019	0.0064	CbGpPWpGaD
Zolpidem—CYP2D6—brain—multiple sclerosis	0.000189	0.00675	CbGeAlD
Zolpidem—Shock—Prednisone—multiple sclerosis	0.000189	0.000469	CcSEcCtD
Zolpidem—Pain—Dexamethasone—multiple sclerosis	0.000189	0.000468	CcSEcCtD
Zolpidem—Pain—Betamethasone—multiple sclerosis	0.000189	0.000468	CcSEcCtD
Zolpidem—Nervous system disorder—Prednisone—multiple sclerosis	0.000189	0.000467	CcSEcCtD
Zolpidem—Tachycardia—Prednisone—multiple sclerosis	0.000188	0.000465	CcSEcCtD
Zolpidem—Skin disorder—Prednisone—multiple sclerosis	0.000187	0.000463	CcSEcCtD
Zolpidem—Hyperhidrosis—Prednisone—multiple sclerosis	0.000186	0.000461	CcSEcCtD
Zolpidem—Vision blurred—Methotrexate—multiple sclerosis	0.000186	0.00046	CcSEcCtD
Zolpidem—Anorexia—Prednisone—multiple sclerosis	0.000183	0.000454	CcSEcCtD
Zolpidem—Ill-defined disorder—Methotrexate—multiple sclerosis	0.000183	0.000453	CcSEcCtD
Zolpidem—Anaemia—Methotrexate—multiple sclerosis	0.000182	0.000451	CcSEcCtD
Zolpidem—Feeling abnormal—Betamethasone—multiple sclerosis	0.000182	0.000451	CcSEcCtD
Zolpidem—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000182	0.000451	CcSEcCtD
Zolpidem—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000181	0.000447	CcSEcCtD
Zolpidem—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000181	0.000447	CcSEcCtD
Zolpidem—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000179	0.000444	CcSEcCtD
Zolpidem—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000179	0.000443	CcSEcCtD
Zolpidem—Malaise—Methotrexate—multiple sclerosis	0.000178	0.00044	CcSEcCtD
Zolpidem—Vertigo—Methotrexate—multiple sclerosis	0.000177	0.000438	CcSEcCtD
Zolpidem—Leukopenia—Methotrexate—multiple sclerosis	0.000176	0.000437	CcSEcCtD
Zolpidem—Urticaria—Dexamethasone—multiple sclerosis	0.000175	0.000435	CcSEcCtD
Zolpidem—Urticaria—Betamethasone—multiple sclerosis	0.000175	0.000435	CcSEcCtD
Zolpidem—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.000175	0.000434	CcSEcCtD
Zolpidem—Dizziness—Prednisolone—multiple sclerosis	0.000175	0.000434	CcSEcCtD
Zolpidem—Asthenia—Triamcinolone—multiple sclerosis	0.000175	0.000433	CcSEcCtD
Zolpidem—Body temperature increased—Betamethasone—multiple sclerosis	0.000175	0.000432	CcSEcCtD
Zolpidem—Body temperature increased—Dexamethasone—multiple sclerosis	0.000175	0.000432	CcSEcCtD
Zolpidem—Abdominal pain—Dexamethasone—multiple sclerosis	0.000175	0.000432	CcSEcCtD
Zolpidem—Abdominal pain—Betamethasone—multiple sclerosis	0.000175	0.000432	CcSEcCtD
Zolpidem—Asthenia—Methylprednisolone—multiple sclerosis	0.000174	0.000432	CcSEcCtD
Zolpidem—Insomnia—Prednisone—multiple sclerosis	0.000174	0.000431	CcSEcCtD
Zolpidem—Paraesthesia—Prednisone—multiple sclerosis	0.000173	0.000428	CcSEcCtD
Zolpidem—Pruritus—Triamcinolone—multiple sclerosis	0.000172	0.000427	CcSEcCtD
Zolpidem—Cough—Methotrexate—multiple sclerosis	0.000172	0.000426	CcSEcCtD
Zolpidem—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12A—multiple sclerosis	0.000172	0.00579	CbGpPWpGaD
Zolpidem—Pruritus—Methylprednisolone—multiple sclerosis	0.000172	0.000426	CcSEcCtD
Zolpidem—Dyspepsia—Prednisone—multiple sclerosis	0.000169	0.000419	CcSEcCtD
Zolpidem—Myalgia—Methotrexate—multiple sclerosis	0.000168	0.000415	CcSEcCtD
Zolpidem—Arthralgia—Methotrexate—multiple sclerosis	0.000168	0.000415	CcSEcCtD
Zolpidem—Chest pain—Methotrexate—multiple sclerosis	0.000168	0.000415	CcSEcCtD
Zolpidem—Decreased appetite—Prednisone—multiple sclerosis	0.000167	0.000414	CcSEcCtD
Zolpidem—Rash—Prednisolone—multiple sclerosis	0.000167	0.000413	CcSEcCtD
Zolpidem—Dermatitis—Prednisolone—multiple sclerosis	0.000167	0.000413	CcSEcCtD
Zolpidem—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	0.000166	0.000412	CcSEcCtD
Zolpidem—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000166	0.000412	CcSEcCtD
Zolpidem—Fatigue—Prednisone—multiple sclerosis	0.000166	0.000411	CcSEcCtD
Zolpidem—Headache—Prednisolone—multiple sclerosis	0.000166	0.000411	CcSEcCtD
Zolpidem—Discomfort—Methotrexate—multiple sclerosis	0.000166	0.00041	CcSEcCtD
Zolpidem—Constipation—Prednisone—multiple sclerosis	0.000164	0.000407	CcSEcCtD
Zolpidem—CYP1A2—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000162	0.00547	CbGpPWpGaD
Zolpidem—CYP1A2—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000162	0.00547	CbGpPWpGaD
Zolpidem—Confusional state—Methotrexate—multiple sclerosis	0.000162	0.000401	CcSEcCtD
Zolpidem—Dizziness—Triamcinolone—multiple sclerosis	0.000161	0.000399	CcSEcCtD
Zolpidem—Anaphylactic shock—Methotrexate—multiple sclerosis	0.000161	0.000398	CcSEcCtD
Zolpidem—Dizziness—Methylprednisolone—multiple sclerosis	0.000161	0.000398	CcSEcCtD
Zolpidem—Infection—Methotrexate—multiple sclerosis	0.00016	0.000396	CcSEcCtD
Zolpidem—Feeling abnormal—Prednisone—multiple sclerosis	0.000158	0.000393	CcSEcCtD
Zolpidem—Asthenia—Dexamethasone—multiple sclerosis	0.000158	0.000393	CcSEcCtD
Zolpidem—Asthenia—Betamethasone—multiple sclerosis	0.000158	0.000393	CcSEcCtD
Zolpidem—Nervous system disorder—Methotrexate—multiple sclerosis	0.000158	0.00039	CcSEcCtD
Zolpidem—Gastrointestinal pain—Prednisone—multiple sclerosis	0.000157	0.00039	CcSEcCtD
Zolpidem—Nausea—Prednisolone—multiple sclerosis	0.000157	0.000389	CcSEcCtD
Zolpidem—Pruritus—Dexamethasone—multiple sclerosis	0.000156	0.000387	CcSEcCtD
Zolpidem—Pruritus—Betamethasone—multiple sclerosis	0.000156	0.000387	CcSEcCtD
Zolpidem—Skin disorder—Methotrexate—multiple sclerosis	0.000156	0.000387	CcSEcCtD
Zolpidem—Hyperhidrosis—Methotrexate—multiple sclerosis	0.000155	0.000385	CcSEcCtD
Zolpidem—Vomiting—Triamcinolone—multiple sclerosis	0.000155	0.000383	CcSEcCtD
Zolpidem—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000155	0.00521	CbGpPWpGaD
Zolpidem—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000155	0.00521	CbGpPWpGaD
Zolpidem—Vomiting—Methylprednisolone—multiple sclerosis	0.000154	0.000383	CcSEcCtD
Zolpidem—Rash—Triamcinolone—multiple sclerosis	0.000153	0.00038	CcSEcCtD
Zolpidem—Dermatitis—Triamcinolone—multiple sclerosis	0.000153	0.00038	CcSEcCtD
Zolpidem—Anorexia—Methotrexate—multiple sclerosis	0.000153	0.00038	CcSEcCtD
Zolpidem—Rash—Methylprednisolone—multiple sclerosis	0.000153	0.000379	CcSEcCtD
Zolpidem—Dermatitis—Methylprednisolone—multiple sclerosis	0.000153	0.000379	CcSEcCtD
Zolpidem—Urticaria—Prednisone—multiple sclerosis	0.000153	0.000378	CcSEcCtD
Zolpidem—CYP3A4—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000153	0.00514	CbGpPWpGaD
Zolpidem—CYP3A4—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000153	0.00514	CbGpPWpGaD
Zolpidem—Headache—Triamcinolone—multiple sclerosis	0.000152	0.000378	CcSEcCtD
Zolpidem—Headache—Methylprednisolone—multiple sclerosis	0.000152	0.000377	CcSEcCtD
Zolpidem—Body temperature increased—Prednisone—multiple sclerosis	0.000152	0.000377	CcSEcCtD
Zolpidem—Abdominal pain—Prednisone—multiple sclerosis	0.000152	0.000377	CcSEcCtD
Zolpidem—Diarrhoea—Betamethasone—multiple sclerosis	0.000151	0.000374	CcSEcCtD
Zolpidem—Diarrhoea—Dexamethasone—multiple sclerosis	0.000151	0.000374	CcSEcCtD
Zolpidem—Hypotension—Methotrexate—multiple sclerosis	0.00015	0.000372	CcSEcCtD
Zolpidem—GABRA1—SIDS Susceptibility Pathways—AQP4—multiple sclerosis	0.00015	0.00506	CbGpPWpGaD
Zolpidem—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	0.000146	0.000363	CcSEcCtD
Zolpidem—Dizziness—Dexamethasone—multiple sclerosis	0.000146	0.000362	CcSEcCtD
Zolpidem—Dizziness—Betamethasone—multiple sclerosis	0.000146	0.000362	CcSEcCtD
Zolpidem—Insomnia—Methotrexate—multiple sclerosis	0.000145	0.00036	CcSEcCtD
Zolpidem—Nausea—Triamcinolone—multiple sclerosis	0.000145	0.000358	CcSEcCtD
Zolpidem—Paraesthesia—Methotrexate—multiple sclerosis	0.000144	0.000358	CcSEcCtD
Zolpidem—Nausea—Methylprednisolone—multiple sclerosis	0.000144	0.000357	CcSEcCtD
Zolpidem—Dyspnoea—Methotrexate—multiple sclerosis	0.000143	0.000355	CcSEcCtD
Zolpidem—CYP3A5—Biological oxidations—CYP24A1—multiple sclerosis	0.000143	0.00482	CbGpPWpGaD
Zolpidem—CYP3A5—Biological oxidations—CYP27B1—multiple sclerosis	0.000143	0.00482	CbGpPWpGaD
Zolpidem—Somnolence—Methotrexate—multiple sclerosis	0.000143	0.000354	CcSEcCtD
Zolpidem—Hypersensitivity—Prednisone—multiple sclerosis	0.000142	0.000351	CcSEcCtD
Zolpidem—Dyspepsia—Methotrexate—multiple sclerosis	0.000141	0.00035	CcSEcCtD
Zolpidem—CYP3A5—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000141	0.00476	CbGpPWpGaD
Zolpidem—CYP3A5—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000141	0.00476	CbGpPWpGaD
Zolpidem—Vomiting—Dexamethasone—multiple sclerosis	0.00014	0.000348	CcSEcCtD
Zolpidem—Vomiting—Betamethasone—multiple sclerosis	0.00014	0.000348	CcSEcCtD
Zolpidem—Decreased appetite—Methotrexate—multiple sclerosis	0.00014	0.000346	CcSEcCtD
Zolpidem—Rash—Betamethasone—multiple sclerosis	0.000139	0.000345	CcSEcCtD
Zolpidem—Rash—Dexamethasone—multiple sclerosis	0.000139	0.000345	CcSEcCtD
Zolpidem—Dermatitis—Betamethasone—multiple sclerosis	0.000139	0.000345	CcSEcCtD
Zolpidem—Dermatitis—Dexamethasone—multiple sclerosis	0.000139	0.000345	CcSEcCtD
Zolpidem—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—multiple sclerosis	0.000139	0.00467	CbGpPWpGaD
Zolpidem—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.000139	0.000344	CcSEcCtD
Zolpidem—Fatigue—Methotrexate—multiple sclerosis	0.000139	0.000343	CcSEcCtD
Zolpidem—Headache—Betamethasone—multiple sclerosis	0.000138	0.000343	CcSEcCtD
Zolpidem—Headache—Dexamethasone—multiple sclerosis	0.000138	0.000343	CcSEcCtD
Zolpidem—Asthenia—Prednisone—multiple sclerosis	0.000138	0.000342	CcSEcCtD
Zolpidem—Pain—Methotrexate—multiple sclerosis	0.000137	0.00034	CcSEcCtD
Zolpidem—Pruritus—Prednisone—multiple sclerosis	0.000136	0.000337	CcSEcCtD
Zolpidem—PTGS1—Overview of nanoparticle effects—TNF—multiple sclerosis	0.000136	0.00457	CbGpPWpGaD
Zolpidem—Feeling abnormal—Methotrexate—multiple sclerosis	0.000132	0.000328	CcSEcCtD
Zolpidem—Diarrhoea—Prednisone—multiple sclerosis	0.000132	0.000326	CcSEcCtD
Zolpidem—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.000131	0.000326	CcSEcCtD
Zolpidem—Nausea—Betamethasone—multiple sclerosis	0.000131	0.000325	CcSEcCtD
Zolpidem—Nausea—Dexamethasone—multiple sclerosis	0.000131	0.000325	CcSEcCtD
Zolpidem—Urticaria—Methotrexate—multiple sclerosis	0.000128	0.000316	CcSEcCtD
Zolpidem—Dizziness—Prednisone—multiple sclerosis	0.000127	0.000315	CcSEcCtD
Zolpidem—Abdominal pain—Methotrexate—multiple sclerosis	0.000127	0.000315	CcSEcCtD
Zolpidem—Body temperature increased—Methotrexate—multiple sclerosis	0.000127	0.000315	CcSEcCtD
Zolpidem—CYP3A4—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000125	0.00422	CbGpPWpGaD
Zolpidem—CYP3A4—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000125	0.00422	CbGpPWpGaD
Zolpidem—Vomiting—Prednisone—multiple sclerosis	0.000122	0.000303	CcSEcCtD
Zolpidem—Rash—Prednisone—multiple sclerosis	0.000121	0.0003	CcSEcCtD
Zolpidem—Dermatitis—Prednisone—multiple sclerosis	0.000121	0.0003	CcSEcCtD
Zolpidem—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000121	0.00407	CbGpPWpGaD
Zolpidem—CYP2C19—Melatonin metabolism and effects—APOE—multiple sclerosis	0.00012	0.00406	CbGpPWpGaD
Zolpidem—Headache—Prednisone—multiple sclerosis	0.00012	0.000298	CcSEcCtD
Zolpidem—GABRB3—BDNF signaling pathway—CNR1—multiple sclerosis	0.000119	0.00402	CbGpPWpGaD
Zolpidem—Hypersensitivity—Methotrexate—multiple sclerosis	0.000118	0.000293	CcSEcCtD
Zolpidem—Asthenia—Methotrexate—multiple sclerosis	0.000115	0.000286	CcSEcCtD
Zolpidem—Nausea—Prednisone—multiple sclerosis	0.000114	0.000283	CcSEcCtD
Zolpidem—Pruritus—Methotrexate—multiple sclerosis	0.000114	0.000282	CcSEcCtD
Zolpidem—CYP2D6—Melatonin metabolism and effects—APOE—multiple sclerosis	0.000111	0.00373	CbGpPWpGaD
Zolpidem—CYP2C19—Biological oxidations—CYP24A1—multiple sclerosis	0.000111	0.00373	CbGpPWpGaD
Zolpidem—CYP2C19—Biological oxidations—CYP27B1—multiple sclerosis	0.000111	0.00373	CbGpPWpGaD
Zolpidem—Diarrhoea—Methotrexate—multiple sclerosis	0.00011	0.000272	CcSEcCtD
Zolpidem—PTGS1—Overview of nanoparticle effects—IL6—multiple sclerosis	0.000109	0.00368	CbGpPWpGaD
Zolpidem—CYP2C19—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000109	0.00368	CbGpPWpGaD
Zolpidem—CYP2C19—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000109	0.00368	CbGpPWpGaD
Zolpidem—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—multiple sclerosis	0.000108	0.00363	CbGpPWpGaD
Zolpidem—Dizziness—Methotrexate—multiple sclerosis	0.000106	0.000263	CcSEcCtD
Zolpidem—GABRB2—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000106	0.00357	CbGpPWpGaD
Zolpidem—GABRB2—Transmission across Chemical Synapses—BCHE—multiple sclerosis	0.000104	0.0035	CbGpPWpGaD
Zolpidem—CYP3A7—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000104	0.00349	CbGpPWpGaD
Zolpidem—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000103	0.00348	CbGpPWpGaD
Zolpidem—Vomiting—Methotrexate—multiple sclerosis	0.000102	0.000253	CcSEcCtD
Zolpidem—CYP2D6—Biological oxidations—CYP27B1—multiple sclerosis	0.000102	0.00343	CbGpPWpGaD
Zolpidem—CYP2D6—Biological oxidations—CYP24A1—multiple sclerosis	0.000102	0.00343	CbGpPWpGaD
Zolpidem—Rash—Methotrexate—multiple sclerosis	0.000101	0.000251	CcSEcCtD
Zolpidem—Dermatitis—Methotrexate—multiple sclerosis	0.000101	0.000251	CcSEcCtD
Zolpidem—GABRA3—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000101	0.0034	CbGpPWpGaD
Zolpidem—CYP2C9—Biological oxidations—CYP24A1—multiple sclerosis	0.000101	0.0034	CbGpPWpGaD
Zolpidem—CYP2C9—Biological oxidations—CYP27B1—multiple sclerosis	0.000101	0.0034	CbGpPWpGaD
Zolpidem—Headache—Methotrexate—multiple sclerosis	0.000101	0.000249	CcSEcCtD
Zolpidem—CYP2D6—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.0001	0.00338	CbGpPWpGaD
Zolpidem—CYP2D6—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.0001	0.00338	CbGpPWpGaD
Zolpidem—CYP2C9—Metapathway biotransformation—CYP27B1—multiple sclerosis	9.96e-05	0.00335	CbGpPWpGaD
Zolpidem—CYP2C9—Metapathway biotransformation—CYP24A1—multiple sclerosis	9.96e-05	0.00335	CbGpPWpGaD
Zolpidem—GABRA2—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	9.92e-05	0.00334	CbGpPWpGaD
Zolpidem—GABRA3—Transmission across Chemical Synapses—BCHE—multiple sclerosis	9.92e-05	0.00334	CbGpPWpGaD
Zolpidem—GABRB3—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	9.86e-05	0.00332	CbGpPWpGaD
Zolpidem—GABRA2—Transmission across Chemical Synapses—BCHE—multiple sclerosis	9.75e-05	0.00328	CbGpPWpGaD
Zolpidem—GABRB3—Transmission across Chemical Synapses—BCHE—multiple sclerosis	9.69e-05	0.00326	CbGpPWpGaD
Zolpidem—GABRG2—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	9.68e-05	0.00326	CbGpPWpGaD
Zolpidem—GABRB3—BDNF signaling pathway—BDNF—multiple sclerosis	9.65e-05	0.00325	CbGpPWpGaD
Zolpidem—Nausea—Methotrexate—multiple sclerosis	9.54e-05	0.000237	CcSEcCtD
Zolpidem—CYP1A2—Estrogen Receptor Pathway—STAT3—multiple sclerosis	9.53e-05	0.00321	CbGpPWpGaD
Zolpidem—GABRG2—Transmission across Chemical Synapses—BCHE—multiple sclerosis	9.51e-05	0.0032	CbGpPWpGaD
Zolpidem—CYP1A2—Melatonin metabolism and effects—APOE—multiple sclerosis	9.39e-05	0.00316	CbGpPWpGaD
Zolpidem—CYP1A2—Biological oxidations—CYP27B1—multiple sclerosis	8.63e-05	0.00291	CbGpPWpGaD
Zolpidem—CYP1A2—Biological oxidations—CYP24A1—multiple sclerosis	8.63e-05	0.00291	CbGpPWpGaD
Zolpidem—GABRB3—BDNF signaling pathway—SPP1—multiple sclerosis	8.56e-05	0.00288	CbGpPWpGaD
Zolpidem—CYP1A2—Metapathway biotransformation—CYP24A1—multiple sclerosis	8.51e-05	0.00287	CbGpPWpGaD
Zolpidem—CYP1A2—Metapathway biotransformation—CYP27B1—multiple sclerosis	8.51e-05	0.00287	CbGpPWpGaD
Zolpidem—GABRA1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	8.46e-05	0.00285	CbGpPWpGaD
Zolpidem—CYP3A7—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	8.39e-05	0.00283	CbGpPWpGaD
Zolpidem—GABRA1—Transmission across Chemical Synapses—BCHE—multiple sclerosis	8.31e-05	0.0028	CbGpPWpGaD
Zolpidem—PTGS1—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	8.13e-05	0.00274	CbGpPWpGaD
Zolpidem—PTGS1—Selenium Micronutrient Network—ICAM1—multiple sclerosis	8.07e-05	0.00272	CbGpPWpGaD
Zolpidem—GABRB2—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	8.02e-05	0.0027	CbGpPWpGaD
Zolpidem—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	7.97e-05	0.00268	CbGpPWpGaD
Zolpidem—GABRB2—Neuronal System—BCHE—multiple sclerosis	7.97e-05	0.00268	CbGpPWpGaD
Zolpidem—GABRA1—SIDS Susceptibility Pathways—BDNF—multiple sclerosis	7.77e-05	0.00262	CbGpPWpGaD
Zolpidem—GABRA3—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	7.65e-05	0.00258	CbGpPWpGaD
Zolpidem—GABRA3—Neuronal System—BCHE—multiple sclerosis	7.6e-05	0.00256	CbGpPWpGaD
Zolpidem—GABRA2—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	7.52e-05	0.00253	CbGpPWpGaD
Zolpidem—CYP3A5—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	7.48e-05	0.00252	CbGpPWpGaD
Zolpidem—GABRB3—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	7.47e-05	0.00252	CbGpPWpGaD
Zolpidem—GABRA2—Neuronal System—BCHE—multiple sclerosis	7.47e-05	0.00252	CbGpPWpGaD
Zolpidem—GABRB3—Neuronal System—BCHE—multiple sclerosis	7.42e-05	0.0025	CbGpPWpGaD
Zolpidem—GABRA1—SIDS Susceptibility Pathways—IL10—multiple sclerosis	7.42e-05	0.0025	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	7.38e-05	0.00248	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	7.38e-05	0.00248	CbGpPWpGaD
Zolpidem—GABRG2—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	7.34e-05	0.00247	CbGpPWpGaD
Zolpidem—GABRG2—Neuronal System—BCHE—multiple sclerosis	7.29e-05	0.00245	CbGpPWpGaD
Zolpidem—PTGS1—Selenium Micronutrient Network—CCL2—multiple sclerosis	7.23e-05	0.00243	CbGpPWpGaD
Zolpidem—PTGS1—Selenium Micronutrient Network—ALB—multiple sclerosis	6.73e-05	0.00227	CbGpPWpGaD
Zolpidem—CYP3A4—Biological oxidations—CYP27B1—multiple sclerosis	6.66e-05	0.00224	CbGpPWpGaD
Zolpidem—CYP3A4—Biological oxidations—CYP24A1—multiple sclerosis	6.66e-05	0.00224	CbGpPWpGaD
Zolpidem—CYP3A4—Metapathway biotransformation—CYP27B1—multiple sclerosis	6.57e-05	0.00221	CbGpPWpGaD
Zolpidem—CYP3A4—Metapathway biotransformation—CYP24A1—multiple sclerosis	6.57e-05	0.00221	CbGpPWpGaD
Zolpidem—GABRA1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	6.41e-05	0.00216	CbGpPWpGaD
Zolpidem—GABRA1—Neuronal System—BCHE—multiple sclerosis	6.37e-05	0.00215	CbGpPWpGaD
Zolpidem—GABRB2—Transmembrane transport of small molecules—AQP4—multiple sclerosis	6.34e-05	0.00214	CbGpPWpGaD
Zolpidem—PTGS1—Selenium Micronutrient Network—IFNG—multiple sclerosis	6.14e-05	0.00207	CbGpPWpGaD
Zolpidem—CYP3A5—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	6.07e-05	0.00204	CbGpPWpGaD
Zolpidem—GABRA3—Transmembrane transport of small molecules—AQP4—multiple sclerosis	6.05e-05	0.00204	CbGpPWpGaD
Zolpidem—GABRA2—Transmembrane transport of small molecules—AQP4—multiple sclerosis	5.95e-05	0.002	CbGpPWpGaD
Zolpidem—GABRB3—Transmembrane transport of small molecules—AQP4—multiple sclerosis	5.91e-05	0.00199	CbGpPWpGaD
Zolpidem—GABRG2—Transmembrane transport of small molecules—AQP4—multiple sclerosis	5.8e-05	0.00195	CbGpPWpGaD
Zolpidem—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	5.78e-05	0.00195	CbGpPWpGaD
Zolpidem—GABRB2—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	5.61e-05	0.00189	CbGpPWpGaD
Zolpidem—PTGS1—Selenium Micronutrient Network—IL1B—multiple sclerosis	5.48e-05	0.00185	CbGpPWpGaD
Zolpidem—GABRA3—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	5.35e-05	0.0018	CbGpPWpGaD
Zolpidem—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	5.32e-05	0.00179	CbGpPWpGaD
Zolpidem—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	5.27e-05	0.00178	CbGpPWpGaD
Zolpidem—GABRA2—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	5.26e-05	0.00177	CbGpPWpGaD
Zolpidem—GABRB3—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	5.22e-05	0.00176	CbGpPWpGaD
Zolpidem—GABRG2—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	5.13e-05	0.00173	CbGpPWpGaD
Zolpidem—GABRA1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	5.07e-05	0.00171	CbGpPWpGaD
Zolpidem—CYP3A7—Metabolism—SRM—multiple sclerosis	4.81e-05	0.00162	CbGpPWpGaD
Zolpidem—CYP2C19—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	4.69e-05	0.00158	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—SRM—multiple sclerosis	4.66e-05	0.00157	CbGpPWpGaD
Zolpidem—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—multiple sclerosis	4.64e-05	0.00156	CbGpPWpGaD
Zolpidem—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	4.51e-05	0.00152	CbGpPWpGaD
Zolpidem—GABRA1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	4.48e-05	0.00151	CbGpPWpGaD
Zolpidem—CYP3A7—Biological oxidations—POMC—multiple sclerosis	4.46e-05	0.0015	CbGpPWpGaD
Zolpidem—PTGS1—Biological oxidations—POMC—multiple sclerosis	4.32e-05	0.00146	CbGpPWpGaD
Zolpidem—CYP2D6—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	4.31e-05	0.00145	CbGpPWpGaD
Zolpidem—CYP2C9—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	4.28e-05	0.00144	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	4.25e-05	0.00143	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	4.25e-05	0.00143	CbGpPWpGaD
Zolpidem—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—multiple sclerosis	4.14e-05	0.00139	CbGpPWpGaD
Zolpidem—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—multiple sclerosis	4.12e-05	0.00139	CbGpPWpGaD
Zolpidem—GABRB3—BDNF signaling pathway—STAT3—multiple sclerosis	4.05e-05	0.00136	CbGpPWpGaD
Zolpidem—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	4.04e-05	0.00136	CbGpPWpGaD
Zolpidem—PTGS1—Selenium Micronutrient Network—TNF—multiple sclerosis	3.98e-05	0.00134	CbGpPWpGaD
Zolpidem—GABRA1—SIDS Susceptibility Pathways—IL1B—multiple sclerosis	3.89e-05	0.00131	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	3.88e-05	0.00131	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	3.88e-05	0.00131	CbGpPWpGaD
Zolpidem—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	3.86e-05	0.0013	CbGpPWpGaD
Zolpidem—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	3.79e-05	0.00128	CbGpPWpGaD
Zolpidem—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	3.77e-05	0.00127	CbGpPWpGaD
Zolpidem—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	3.7e-05	0.00125	CbGpPWpGaD
Zolpidem—GABRB3—BDNF signaling pathway—MAPK1—multiple sclerosis	3.68e-05	0.00124	CbGpPWpGaD
Zolpidem—CYP1A2—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	3.65e-05	0.00123	CbGpPWpGaD
Zolpidem—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	3.48e-05	0.00117	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—SRM—multiple sclerosis	3.48e-05	0.00117	CbGpPWpGaD
Zolpidem—CYP3A7—Metabolism—CYP24A1—multiple sclerosis	3.39e-05	0.00114	CbGpPWpGaD
Zolpidem—CYP3A7—Metabolism—CYP27B1—multiple sclerosis	3.39e-05	0.00114	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	3.31e-05	0.00112	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	3.31e-05	0.00112	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—CYP27B1—multiple sclerosis	3.28e-05	0.00111	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—CYP24A1—multiple sclerosis	3.28e-05	0.00111	CbGpPWpGaD
Zolpidem—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	3.23e-05	0.00109	CbGpPWpGaD
Zolpidem—CYP1A2—Aryl Hydrocarbon Receptor—MYC—multiple sclerosis	3.22e-05	0.00109	CbGpPWpGaD
Zolpidem—CYP3A5—Biological oxidations—POMC—multiple sclerosis	3.22e-05	0.00109	CbGpPWpGaD
Zolpidem—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—multiple sclerosis	3.21e-05	0.00108	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	3.21e-05	0.00108	CbGpPWpGaD
Zolpidem—PTGS1—Selenium Micronutrient Network—IL6—multiple sclerosis	3.21e-05	0.00108	CbGpPWpGaD
Zolpidem—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—multiple sclerosis	3.15e-05	0.00106	CbGpPWpGaD
Zolpidem—CYP3A7—Metabolism—GPC5—multiple sclerosis	3.1e-05	0.00104	CbGpPWpGaD
Zolpidem—GABRB2—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	3.04e-05	0.00102	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—GPC5—multiple sclerosis	3e-05	0.00101	CbGpPWpGaD
Zolpidem—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—multiple sclerosis	3e-05	0.00101	CbGpPWpGaD
Zolpidem—CYP1A2—Aryl Hydrocarbon Receptor—TNF—multiple sclerosis	3e-05	0.00101	CbGpPWpGaD
Zolpidem—GABRA3—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	2.9e-05	0.000977	CbGpPWpGaD
Zolpidem—GABRA2—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	2.85e-05	0.00096	CbGpPWpGaD
Zolpidem—GABRB3—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	2.83e-05	0.000953	CbGpPWpGaD
Zolpidem—GABRA1—SIDS Susceptibility Pathways—TNF—multiple sclerosis	2.82e-05	0.000951	CbGpPWpGaD
Zolpidem—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	2.82e-05	0.00095	CbGpPWpGaD
Zolpidem—GABRG2—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	2.78e-05	0.000936	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—SRM—multiple sclerosis	2.69e-05	0.000905	CbGpPWpGaD
Zolpidem—CYP3A7—Metabolism—RRM1—multiple sclerosis	2.57e-05	0.000865	CbGpPWpGaD
Zolpidem—CYP2C19—Biological oxidations—POMC—multiple sclerosis	2.49e-05	0.000839	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—RRM1—multiple sclerosis	2.49e-05	0.000838	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—SRM—multiple sclerosis	2.47e-05	0.000833	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—SRM—multiple sclerosis	2.45e-05	0.000825	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—CYP27B1—multiple sclerosis	2.45e-05	0.000825	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—CYP24A1—multiple sclerosis	2.45e-05	0.000825	CbGpPWpGaD
Zolpidem—GABRA1—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	2.43e-05	0.000818	CbGpPWpGaD
Zolpidem—GABRB2—Neuronal System—MAPK1—multiple sclerosis	2.33e-05	0.000784	CbGpPWpGaD
Zolpidem—CYP2D6—Biological oxidations—POMC—multiple sclerosis	2.29e-05	0.000772	CbGpPWpGaD
Zolpidem—GABRA1—SIDS Susceptibility Pathways—IL6—multiple sclerosis	2.28e-05	0.000767	CbGpPWpGaD
Zolpidem—CYP2C9—Biological oxidations—POMC—multiple sclerosis	2.27e-05	0.000765	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—GPC5—multiple sclerosis	2.24e-05	0.000755	CbGpPWpGaD
Zolpidem—GABRA3—Neuronal System—MAPK1—multiple sclerosis	2.22e-05	0.000748	CbGpPWpGaD
Zolpidem—GABRA2—Neuronal System—MAPK1—multiple sclerosis	2.18e-05	0.000735	CbGpPWpGaD
Zolpidem—GABRB3—Neuronal System—MAPK1—multiple sclerosis	2.17e-05	0.000731	CbGpPWpGaD
Zolpidem—GABRG2—Neuronal System—MAPK1—multiple sclerosis	2.13e-05	0.000717	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—SRM—multiple sclerosis	2.09e-05	0.000705	CbGpPWpGaD
Zolpidem—GABRB2—Transmembrane transport of small molecules—ALB—multiple sclerosis	2.02e-05	0.00068	CbGpPWpGaD
Zolpidem—CYP1A2—Biological oxidations—POMC—multiple sclerosis	1.94e-05	0.000654	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.93e-05	0.00065	CbGpPWpGaD
Zolpidem—GABRA3—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.93e-05	0.000649	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—CYP27B1—multiple sclerosis	1.89e-05	0.000638	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—CYP24A1—multiple sclerosis	1.89e-05	0.000638	CbGpPWpGaD
Zolpidem—GABRA2—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.89e-05	0.000637	CbGpPWpGaD
Zolpidem—GABRB3—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.88e-05	0.000633	CbGpPWpGaD
Zolpidem—GABRA1—Neuronal System—MAPK1—multiple sclerosis	1.86e-05	0.000627	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—RRM1—multiple sclerosis	1.86e-05	0.000625	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	1.85e-05	0.000623	CbGpPWpGaD
Zolpidem—GABRG2—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.85e-05	0.000622	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—CYP27B1—multiple sclerosis	1.74e-05	0.000587	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—CYP24A1—multiple sclerosis	1.74e-05	0.000587	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—GPC5—multiple sclerosis	1.73e-05	0.000583	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—CYP27B1—multiple sclerosis	1.73e-05	0.000582	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—CYP24A1—multiple sclerosis	1.73e-05	0.000582	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	1.69e-05	0.000568	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.66e-05	0.000559	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—SRM—multiple sclerosis	1.62e-05	0.000544	CbGpPWpGaD
Zolpidem—GABRA1—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.61e-05	0.000543	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—GPC5—multiple sclerosis	1.59e-05	0.000537	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—GPC5—multiple sclerosis	1.58e-05	0.000532	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.51e-05	0.000509	CbGpPWpGaD
Zolpidem—CYP3A4—Biological oxidations—POMC—multiple sclerosis	1.5e-05	0.000505	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—CYP24A1—multiple sclerosis	1.48e-05	0.000497	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—CYP27B1—multiple sclerosis	1.48e-05	0.000497	CbGpPWpGaD
Zolpidem—CYP3A7—Metabolism—BCHE—multiple sclerosis	1.47e-05	0.000497	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	1.44e-05	0.000486	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—RRM1—multiple sclerosis	1.44e-05	0.000483	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—BCHE—multiple sclerosis	1.43e-05	0.000482	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—GPC5—multiple sclerosis	1.35e-05	0.000455	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—RRM1—multiple sclerosis	1.32e-05	0.000445	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—RRM1—multiple sclerosis	1.31e-05	0.000441	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	1.14e-05	0.000384	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	1.14e-05	0.000384	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—RRM1—multiple sclerosis	1.12e-05	0.000377	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.11e-05	0.000375	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—BCHE—multiple sclerosis	1.07e-05	0.000359	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—GPC5—multiple sclerosis	1.04e-05	0.000351	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.02e-05	0.000342	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	9.57e-06	0.000322	CbGpPWpGaD
Zolpidem—CYP3A7—Metabolism—APOE—multiple sclerosis	8.87e-06	0.000299	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	8.72e-06	0.000294	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	8.72e-06	0.000294	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	8.68e-06	0.000292	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—RRM1—multiple sclerosis	8.63e-06	0.000291	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—APOE—multiple sclerosis	8.6e-06	0.00029	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—BCHE—multiple sclerosis	8.24e-06	0.000278	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	7.95e-06	0.000268	CbGpPWpGaD
Zolpidem—CYP3A7—Metabolism—POMC—multiple sclerosis	7.62e-06	0.000257	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—BCHE—multiple sclerosis	7.58e-06	0.000255	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—BCHE—multiple sclerosis	7.52e-06	0.000253	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	7.45e-06	0.000251	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—POMC—multiple sclerosis	7.39e-06	0.000249	CbGpPWpGaD
Zolpidem—CYP3A7—Metabolism—ALB—multiple sclerosis	6.95e-06	0.000234	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	6.79e-06	0.000229	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—ALB—multiple sclerosis	6.74e-06	0.000227	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—BCHE—multiple sclerosis	6.42e-06	0.000216	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—APOE—multiple sclerosis	6.41e-06	0.000216	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—POMC—multiple sclerosis	5.51e-06	0.000186	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—ALB—multiple sclerosis	5.02e-06	0.000169	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—APOE—multiple sclerosis	4.96e-06	0.000167	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—BCHE—multiple sclerosis	4.96e-06	0.000167	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—APOE—multiple sclerosis	4.56e-06	0.000154	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—APOE—multiple sclerosis	4.52e-06	0.000152	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—POMC—multiple sclerosis	4.26e-06	0.000143	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—POMC—multiple sclerosis	3.92e-06	0.000132	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—POMC—multiple sclerosis	3.88e-06	0.000131	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—ALB—multiple sclerosis	3.88e-06	0.000131	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—APOE—multiple sclerosis	3.86e-06	0.00013	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—ALB—multiple sclerosis	3.57e-06	0.00012	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—ALB—multiple sclerosis	3.54e-06	0.000119	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—POMC—multiple sclerosis	3.32e-06	0.000112	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—ALB—multiple sclerosis	3.03e-06	0.000102	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—APOE—multiple sclerosis	2.98e-06	0.0001	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—POMC—multiple sclerosis	2.56e-06	8.63e-05	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—ALB—multiple sclerosis	2.34e-06	7.87e-05	CbGpPWpGaD
